Future US Transfusion Diagnostic Testing Market Outlook
NEW YORK, Feb. 13, 2012 /PRNewswire/ – Reportlinker.com announces that a new market research report is available in its catalogue:
Future US Transfusion Diagnostic Testing Market Outlook
http://www.reportlinker.com/p0770979/Future-US-Transfusion-Diagnostic-Testing-Market-Outlook.html#utm_source=prnewswireutm_medium=prutm_campaign=In_Vitro_Diagnostic
Highlights
- Comprehensive 460-pages market segmentation analysis of the US transfusion testing market.
- Major issues pertaining to the US transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues.
- Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, hospitals, commercial laboratories, and plasma fractionation facilities.
- Annual placements and installed base estimates for major automated and semi-automated analyzers.
- Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of current and emerging technologies, and their potential market applications.
- Product development opportunities for instruments ,consumables, and auxiliary products.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in RD, collaborative arrangements, and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Table of Contents
Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS
- Structure and Composition
- Classification
- Origin of AIDS
- Animal Lentivirus Systems
- Virus Receptors
- HIV Infections in Humans
-Pathogenesis Pathology
-Overview of Course of HIV Infection
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
-Clinical Findings
- Plasma Viral Load
- Pediactric AIDS
-Neurologic Disease
-Opportunistic Infections
-Protozoa
-Fungi
-Bacteria
-Viruses
-Cancer Table of Contents (continued)
- Immunity- Laboratory Diagnosis-Virus Isolation-Serology-Detection of Viral Nucleic Acid or Antigens- Epidemiology-Worldwide Spread of AIDS-United States-Routes of Transmission- Prevention, Treatment, And Control-Antiviral Drugs-Vaccines Against HIV- Transmission of HIV in Blood Products- HIV Transmission in Transplant and Artificial Insemination Recipients- Diagnostic Tests-Enzyme Immunoassay Interpretation-Specificity, Sensitivity, and PredictiveValue of Enzyme Immunoassay- Competition Assays- Western Blot Technique- Immuno-Fluorescence Assay (IFA)- Radioimmunoprecipitation- HIV-1/HIV-2 Combination Testing- Methods of HIV-Antigen Detection- Antigen Assays and Blood Screening- Urine Tests- DNA Probes- Overview- Quantitative Polymerase Chain Reaction- In Situ PCR- Needed Improvements- Viral Load/Drug Resistance Testing- Genotype and Phenotype Testing- Blood Banking Considerationsb. Hepatitis- Hepatitis A- Hepatitis B-Structure and Composition-Replication of Hepatitis B VirusTable of Contents (continued)
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Hepatitis Virus Infections In Humans
-Pathology
- Clinical Findings
- Laboratory Features
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D
-Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D (Delta Agent)
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
-Erythema Infectiosum Slapped (cheek) Table of Contents (continued)
-Adult Polyarthropathy-Transient Aplastic Crisis-Transient Pancytopenia-Red Cell Aplasia in the Immunocompromised-Perinatal Infections- Diagnosis- Treatmentg. Creutzfeldt-Jakob’s Disease- Background- Transmission- Diagnostic Tests- Major Commercial and Academic Players-Bayer-Disease Sciences/BioTec Global-Imperial College School of Medicine-Ortho-Clinical Diagnostics-Pall-ProMetic Life Sciences-Proteome Sciences/Idexx-Q-One Biotech-Serono-U.S. Agricultural Research Service- Drugs- Vaccinesh. Malariai. Chagas Diseasej. Babesiosis3. Pathogen Reduction4. Leukocyte Reduction- Background- MethodsB. Instrumentation ReviewIntroduction1. Abbott Architect i2000 Series2. Abbott AxSYM3. Abbott LCx4. Abbott Prism5. Abbott Quantum II6. Beckman Coulter/Biomek FX7. Beckman Coulter BloodTrack Courier8. Beckman Coulter OLA2500 Table of Contents (continued)
9. Beckman Coulter PK7100
10. Beckman Coulter PK7200
11. Beckman Coulter PK80
12. Beckman Coulter Tango
13. Bio-Rad Elite
14. Bio-Rad GeneScope
15. BioMerieux Bac/Alert
16. Gen-Probe Tigris
17. Grifols Diana
18. Immucor ABS2000
19. Immucor Galileo
20. Immucor Rosys Plato System
21. Nanosphere Verigen Series
22. Ortho AutoVue/ProVue
23. Ortho StarFame Combo
24. Ortho Summit Processor
25. Roche Cobas Amplicor
26. Roches Cobas s 201
27. Sarstedt PVS
28. Siemens BEP 2000
29. Siemens Quadriga
30. Siemens SDA
31. Tecan ELPHAtyper
32. Tecan Genesis FE500
33. Tecan Hemotyper
34. Tecan LS Series
35. Tecan MegaFlex
36. Tecan MiniSwift
C. Major in Vitro Diagnostic Technologies
And Their Potential Applications
1. Molecular Diagnostics
a. Overview
b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Enzyme Amplification
c. Fluorescent Immunoassays
- Fluorescence PolarizationTable of Contents (continued)
d. Luminescence
- Chemiluminescence
- Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Microtitration Plates
5. Information Technology
6. Automation
7. Lasers
8. Robotics
9. Artificial Intelligence
10. Synthetic Red Cell Substitutes
11. Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand’s Factor
g. Fibrinogen
h. t-PA
12. Blood Preservation
13. Autologous Blood Transfusion/Freezing
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
U.S.A.
A. Executive Summary
B. Business Environment
1. Overview
2. Health Care Expenditures
3 Cost Consciousness
4. Industry Consolidation
5. Managed Care
6. Hospitals
7. Admissions
8. Length of StayTable of Contents (continued)
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illnesses
b. Disease Incidence
c. Susceptibility to Latrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
C. Market Structure
D. Market Size, Growth and Major Suppliers’
Consumable Sales, Instrument Placements,
Installed Base and Market Shares
Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
Competitive Assessments
- Abbott
- Beckman Coulter
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- DiagastTable of Contents (continued)
- DiaSorin
- Fujirebio
- Gen-Probe
- Grifols
- Immucor
- Innogenetics
- Ortho-Clinical Diagnostics
- Orchid CellMark
- Novartis Diagnostics
- Proteome Sciences
- Roche
- Siemens
- TecanList of Tables
Major Companies Developing or MarketingBlood Typing and Grouping TestsMajor Companies Developing or MarketingHLA Typing TestsMajor Companies Developing or MarketingAIDS TestsMajor Companies Developing or MarketingHepatitis TestsMajor Companies Developing or MarketingCMV TestsMajor Companies Developing or MarketingSyphilis TestsMajor Companies Developing or MarketingBlood Bank AnalyzersWorldwide, All Market Segments, FacilitiesPerforming Blood Bank Tests By CountryWorldwide, All Market Segments, TotalBlood Typing and Grouping Test Volume ForecastBy CountryWorldwide, All Market Segments, TotalInfectious Disease Screening Test Volume ForecastWorldwide, All Market Segments, TotalBlood Typing and Grouping Reagent Market ForecastBy CountryWorldwide, All Market Segments, TotalInfectious Disease Reagent Market Forecast By CountryList of Tables (continued)
Executive Summary Table: U.S.A., Total Blood Bank
Test Volume and Reagent Sales Forecast By Test
Category
U.S.A., Estimated Number of Inpatient and
Ambulatory Surgeries
U.S.A., Facilities Performing Blood
Bank Tests By Market Segment
U.S.A., Hospital Laboratories Performing
Blood Bank Tests By Bed Size
U.S.A., Commercial/Private Laboratories
Performing Blood Bank Tests By Annual
Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood
and Plasma By Market Forecast Segment
U.S.A., Whole Blood and Plasma Collections
By Market Forecast Segment
U.S.A., All Market Segments Blood Typing
and Grouping Test Volume By Market Forecast
Segment
U.S.A., All Market Segments Blood Typing
and Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood
Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Test Volume ForecastList of Tables (continued)
U.S.A., Commercial/Private LaboratoriesBlood Typing and Grouping Test Volume ForecastU.S.A., Plasma Fractionation Centers BloodTyping and Grouping Test Volume ForecastU.S.A., Military Blood Banks Blood Typingand Grouping Test Volume ForecastU.S.A., All Market Segments InfectiousDisease Screening Test Volume Forecast By Market SegmentU.S.A., All Market Segments InfectiousDisease Screening Test Volume ForecastU.S.A., Community and Regional Centers Infectious Disease Screening Test Volume ForecastU.S.A., Plasma Fractionation CentersInfectious Disease Screening Test Volume ForecastU.S.A., Hospital Blood BanksInfectious Disease Screening Test Volume ForecastU.S.A., Military Blood Banks InfectiousDisease Screening Test Volume ForecastU.S.A., All Market Segments Blood Typingand Grouping Reagent Market Forecast By Market SegmentU.S.A., All Market Segments Blood Typingand Grouping Reagent Market Forecast By MarketSegmentList of Tables (continued)
U.S.A., Hospital Blood Banks Blood Typing
And Grouping Reagent Market Forecast by Major
Test
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Commercial/Private Laboratories
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Plasma Fractionation Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Military Blood Banks Blood Typing
And Grouping Reagent Market Forecast By Major Test
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market By Market Forecast
Segment
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market By Market Forecast
Segment
U.S.A., Community and Regional Centers
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Plasma Fractionation Centers
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Hospital Blood Banks
Infectious Disease Screening Reagent Market Forecast
By TestList of Tables (continued)
U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast By Test U.S.A., Major Suppliers of Blood Typingand Grouping Reagents Estimated Sales andMarket SharesU.S.A., HIV/HTLV Blood Screening Market,Reagent Sales by Major SupplierU.S.A., Hepatitis Blood Screening Market,Reagents Sales by Major SupplierU.S.A., Hepatitis C Blood Screening Market,Reagent Sales By Major SupplierU.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major SupplierU.S.A., West Nile Virus NAT Market,Reagent Sales By Major SupplierU.S.A., CMV Blood Screening Market,Reagent Sales By Major SupplierU.S.A., Syphilis Blood Screening Market,Reagent Sales By Major Supplier
To order this report:In Vitro Diagnostic Industry: Future US Transfusion Diagnostic Testing Market Outlook
More
Market Research Report
Check our
Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
No comments:
Post a Comment